These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 16181099)
41. Transgenic overexpression of dystroglycan does not inhibit muscular dystrophy in mdx mice. Hoyte K; Jayasinha V; Xia B; Martin PT Am J Pathol; 2004 Feb; 164(2):711-8. PubMed ID: 14742274 [TBL] [Abstract][Full Text] [Related]
42. A possible role of tryptase in angiogenesis in the brain of mdx mouse, a model of Duchenne muscular dystrophy. Nico B; Marzullo A; Corsi P; Vacca A; Roncali L; Ribatti D Neuroscience; 2004; 123(3):585-8. PubMed ID: 14706770 [TBL] [Abstract][Full Text] [Related]
43. Transient receptor potential channel 6 regulates abnormal cardiac S-nitrosylation in Duchenne muscular dystrophy. Chung HS; Kim GE; Holewinski RJ; Venkatraman V; Zhu G; Bedja D; Kass DA; Van Eyk JE Proc Natl Acad Sci U S A; 2017 Dec; 114(50):E10763-E10771. PubMed ID: 29187535 [TBL] [Abstract][Full Text] [Related]
44. Exercise increases utrophin protein expression in the mdx mouse model of Duchenne muscular dystrophy. Gordon BS; Lowe DA; Kostek MC Muscle Nerve; 2014 Jun; 49(6):915-8. PubMed ID: 24375286 [TBL] [Abstract][Full Text] [Related]
45. Brain metabolism is abnormal in the mdx model of Duchenne muscular dystrophy. Tracey I; Dunn JF; Radda GK Brain; 1996 Jun; 119 ( Pt 3)():1039-44. PubMed ID: 8673481 [TBL] [Abstract][Full Text] [Related]
46. Electromyographic studies in mdx and wild-type C57 mice. Han JJ; Carter GT; Ra JJ; Abresch RT; Chamberlain JS; Robinson LR Muscle Nerve; 2006 Feb; 33(2):208-14. PubMed ID: 16281275 [TBL] [Abstract][Full Text] [Related]
47. Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice. Vaillend C; Chaussenot R Hum Mol Genet; 2017 Mar; 26(6):1041-1055. PubMed ID: 28087735 [TBL] [Abstract][Full Text] [Related]
48. The role of dystrophin in the central nervous system: a mini review. Sekiguchi M Acta Myol; 2005 Oct; 24(2):93-7. PubMed ID: 16550924 [TBL] [Abstract][Full Text] [Related]
49. Determination of qPCR Reference Genes Suitable for Normalizing Gene Expression in a Canine Model of Duchenne Muscular Dystrophy. Hildyard JCW; Taylor-Brown F; Massey C; Wells DJ; Piercy RJ J Neuromuscul Dis; 2018; 5(2):177-191. PubMed ID: 29614692 [TBL] [Abstract][Full Text] [Related]
50. The role of aquaporin-4 in the blood-brain barrier development and integrity: studies in animal and cell culture models. Nicchia GP; Nico B; Camassa LM; Mola MG; Loh N; Dermietzel R; Spray DC; Svelto M; Frigeri A Neuroscience; 2004; 129(4):935-45. PubMed ID: 15561409 [TBL] [Abstract][Full Text] [Related]
51. Isolation and characterization of neural stem cells from dystrophic mdx mouse. Annese T; Corsi P; Ruggieri S; Tamma R; Marinaccio C; Picocci S; Errede M; Specchia G; De Luca A; Frassanito MA; Desantis V; Vacca A; Ribatti D; Nico B Exp Cell Res; 2016 May; 343(2):190-207. PubMed ID: 27015747 [TBL] [Abstract][Full Text] [Related]
52. Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy. Ponnusamy S; Sullivan RD; You D; Zafar N; He Yang C; Thiyagarajan T; Johnson DL; Barrett ML; Koehler NJ; Star M; Stephenson EJ; Bridges D; Cormier SA; Pfeffer LM; Narayanan R Hum Mol Genet; 2017 Jul; 26(13):2526-2540. PubMed ID: 28453658 [TBL] [Abstract][Full Text] [Related]
53. Store-operated calcium entry contributes to abnormal Ca²⁺ signalling in dystrophic mdx mouse myoblasts. Onopiuk M; Brutkowski W; Young C; Krasowska E; Róg J; Ritso M; Wojciechowska S; Arkle S; Zabłocki K; Górecki DC Arch Biochem Biophys; 2015 Mar; 569():1-9. PubMed ID: 25659883 [TBL] [Abstract][Full Text] [Related]
54. Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized (1)H MRS. Xu S; Shi D; Pratt SJP; Zhu W; Marshall A; Lovering RM Neuromuscul Disord; 2015 Oct; 25(10):764-72. PubMed ID: 26236031 [TBL] [Abstract][Full Text] [Related]
55. Wnt signaling pathway improves central inhibitory synaptic transmission in a mouse model of Duchenne muscular dystrophy. Fuenzalida M; Espinoza C; Pérez MÁ; Tapia-Rojas C; Cuitino L; Brandan E; Inestrosa NC Neurobiol Dis; 2016 Feb; 86():109-20. PubMed ID: 26626079 [TBL] [Abstract][Full Text] [Related]
56. Therapeutic effect of camostat mesilate on Duchenne muscular dystrophy in mdx mice. Sawada H; Nagahiro K; Kikukawa Y; Ban S; Kakefuda R; Shiomi T; Yokosawa H Biol Pharm Bull; 2003 Jul; 26(7):1025-7. PubMed ID: 12843632 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of the behavioral characteristics of the mdx mouse model of duchenne muscular dystrophy through operant conditioning procedures. Lewon M; Peters CM; Van Ry PM; Burkin DJ; Hunter KW; Hayes LJ Behav Processes; 2017 Sep; 142():8-20. PubMed ID: 28532665 [TBL] [Abstract][Full Text] [Related]
58. Pregnancy-induced amelioration of muscular dystrophy phenotype in mdx mice via muscle membrane stabilization effect of glucocorticoid. Shimizu-Motohashi Y; Asakura Y; Motohashi N; Belur NR; Baumrucker MG; Asakura A PLoS One; 2015; 10(3):e0120325. PubMed ID: 25775477 [TBL] [Abstract][Full Text] [Related]